Leishmaniasis in humans: drug or vaccine therapy?
M Ghorbani, R Farhoudi - Drug design, development and therapy, 2017 - Taylor & Francis
Leishmania is an obligate intracellular pathogen that invades phagocytic host cells.
Approximately 30 different species of Phlebotomine sand flies can transmit this parasite …
Approximately 30 different species of Phlebotomine sand flies can transmit this parasite …
Leishmaniasis: where are we and where are we heading?
S Sasidharan, P Saudagar - Parasitology research, 2021 - Springer
Leishmaniasis is a zoonotic disease in humans caused by the bite of a parasite-infected
sandfly. The disease, widely referred to as “poor man's disease,” affects millions of people …
sandfly. The disease, widely referred to as “poor man's disease,” affects millions of people …
Quinoxaline, its derivatives and applications: A State of the Art review
JA Pereira, AM Pessoa, MNDS Cordeiro… - European Journal of …, 2015 - Elsevier
Quinoxaline derivatives are an important class of heterocycle compounds, where N replaces
some carbon atoms in the ring of naphthalene. Its molecular formula is C 8 H 6 N 2, formed …
some carbon atoms in the ring of naphthalene. Its molecular formula is C 8 H 6 N 2, formed …
[图书][B] District laboratory practice in tropical countries, part 2
M Cheesbrough - 2006 - books.google.com
This new edition includes an update on HIV disease/AIDS, recently developed HIV rapid
tests to diagnose HIV infection and screen donor blood, and current information on …
tests to diagnose HIV infection and screen donor blood, and current information on …
[HTML][HTML] Drug repurposing and human parasitic protozoan diseases
Parasitic diseases have an enormous health, social and economic impact and are a
particular problem in tropical regions of the world. Diseases caused by protozoa and …
particular problem in tropical regions of the world. Diseases caused by protozoa and …
[HTML][HTML] Pharmaceutically active secondary metabolites of marine actinobacteria
P Manivasagan, J Venkatesan, K Sivakumar… - Microbiological …, 2014 - Elsevier
Marine actinobacteria are one of the most efficient groups of secondary metabolite
producers and are very important from an industrial point of view. Many representatives of …
producers and are very important from an industrial point of view. Many representatives of …
Drug resistance in leishmaniasis
Leishmaniasis is a complex disease, with visceral and cutaneous manifestations, and is
caused by over 15 different species of the protozoan parasite genus Leishmania. There are …
caused by over 15 different species of the protozoan parasite genus Leishmania. There are …
Nanotechnology: intelligent design to treat complex disease
P Couvreur, C Vauthier - Pharmaceutical research, 2006 - Springer
The purpose of this expert review is to discuss the impact of nanotechnology in the treatment
of the major health threats including cancer, infections, metabolic diseases, autoimmune …
of the major health threats including cancer, infections, metabolic diseases, autoimmune …
Leishmaniasis: current status of available drugs and new potential drug targets
The control of Leishmania infection relies primarily on chemotherapy till date. Resistance to
pentavalent antimonials, which have been the recommended drugs to treat cutaneous and …
pentavalent antimonials, which have been the recommended drugs to treat cutaneous and …
Use of antimony in the treatment of leishmaniasis: current status and future directions
In the recent past the standard treatment of kala‐azar involved the use of pentavalent
antimonials Sb (V). Because of progressive rise in treatment failure to Sb (V) was limited its …
antimonials Sb (V). Because of progressive rise in treatment failure to Sb (V) was limited its …